Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd. covers the month of August 2019. The document serves to furnish materials related to an extraordinary general meeting of shareholders scheduled for October 3, 2019, at the company's offices in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing containing notices and proxy materials rather than a financial statement.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this document. The filing focuses solely on the administrative details of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing incorporates by reference a Notice and Proxy Statement (Exhibit 99.1) and a Proxy Card (Exhibit 99.2) for the extraordinary general meeting. No specific guidance, management commentary on operations, risks, or contingencies are detailed within the text of this Form 6-K cover page.
Key Facts for Investors
- The company is convening an extraordinary general meeting on October 3, 2019.
- Shareholders are provided with a Notice and Proxy Statement dated August 29, 2019.
- The filing was signed by Adam Gridley, Chief Executive Officer, on August 29, 2019.
- Entera Bio Ltd. files annual reports under Form 20-F.